Search results
Pages
-
- Effect of erenumab on functional outcomes in patients with episodic migraine in whom 2-4 preventives were not useful
-
- Cortical glutamate and gamma-aminobutyric acid over the course of a provoked migraine attack, a 7 Tesla magnetic resonance spectroscopy study
-
- Responsivity to light in familial hemiplegic migraine type 1 mutant mice reveals frequency-dependent enhancement of visual network excitability
-
- Anti-migraine calcitonin gene-related peptide receptor antagonists worsen cerebral ischemic outcome in mice
-
- Guidelines for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults
-
- MRI evaluation of the relationship between carotid artery endothelial shear stress and brain white matter lesions in migraine
-
- Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine
-
- Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial
-
- Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial